Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
April 3, 2026Mini-Reviews in Medicinal Chemistry

Advances in the Understanding and Mechanisms of Cabergoline-Induced Valvulopathy in Prolactinoma Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

ZTZilong TanTWTengTeng WangWHWei He

Discussion

Loading...

Member takes

Overview

This review examines the mechanisms of valvulopathy in prolactinoma patients treated with cabergoline, suggesting monitoring improvements.

Key Points

  • This review explores the mechanisms underlying cabergoline-induced valvulopathy, particularly in prolactinoma patients.
  • Reviewed existing literature on cabergoline's effects on heart valves
  • Analyzed molecular pathways associated with cabergoline use
  • Discussed inflammatory responses related to valvular disease
  • Identified cabergoline's interaction with catecholaminergic and serotonergic pathways
  • Highlighted concerns over the safety of long-term cabergoline treatment
  • Revealed controversy regarding cabergoline's link to specific heart valve diseases

Cite This Study

Tan et al. (2026) studied this question.

synapsesocial.com/papers/69cf5f105a333a821460dddfhttps://doi.org/10.2174/0113895575419669260114072747
View Full Paper
Ask AI
Bookmark
Share